By March 2010, when Johnson & Johnson filed its financial disclosure with the Securities and Exchange Commission covering the events of the year 2009, the world’s leading healthcare company was forced to list a daunting collection of suits and investigations involving Risperdal.
Calling all HuffPost superfans!
Sign up for membership to become a founding member and help shape HuffPost's next chapter
